key: cord-0292018-7resue10
authors: Miller, Karen B.; Shuparski, Andrew G.; Higgins, Brett W.; Sharma, Siddhartha M.; Milpied, Pierre J.; McHeyzer-Williams, Louise J.; McHeyzer-Williams, Michael G.
title: Follicular helper T cells expressing Blimp1 are specialized for plasma cell differentiation
date: 2022-04-01
journal: bioRxiv
DOI: 10.1101/2022.03.31.486642
sha: 1390ec27fe9763ab53ef27300d53522b185b7c85
doc_id: 292018
cord_uid: 7resue10

B cells differentiate into antibody-producing plasma cells (PC) and germinal center (GC) B cells under the guidance of specialized CD4+ follicular helper T (TFH) cells. Here, we demonstrate that CD4 T cells require Prdm1 expression for both early PC differentiation and post-GC PC formation. Using dual Blimp1/Foxp3 reporter mice and single cell-indexed analysis, we segregate persistent compartments and expressed transcriptional programs of Blimp1+ CXCR5+PD1hi TFH (referred to here as PC-TFH) from canonical Blimp1- Bcl6+ TFH (GC-TFH) and Blimp1+Foxp3+ TFR immune regulators. Antigen recall expands localized PC-TFH compartments with rapidly divergent antigen-specific memory PC-TFH and GC-TFH programs. Thus, Blimp1 is a central mediator of PC-TFH function producing specialized TFH subsets that co-ordinate with GC-TFH function to establish high-affinity long-lasting protective immunity to vaccines and infection. One-Sentence Summary Blimp1 expressing TFH cells express unique transcriptional programs to control PC formation RESEARCH ARTICLE SUMMARY Introduction Adaptive B cell immunity rapidly emerges to form plasma cells (PC) for antibody production and non-PC that enter germinal centers (GC) to evolve higher affinity B cell receptors. Both pathways are essential to long-term high-affinity immune protection. The early PC to GC cell fate division is driven by B cell expression of mutually antagonist transcriptional repressors Blimp1 and Bcl6. This dichotomous B cell outcome is orchestrated through antigen-specific contact by follicular helper T (TFH) cells that express Bcl6 to upregulate CXCR5, localize into B cell regions and express transcriptional programs that influence B cell fate and function. It remains unclear what TFH cell mechanisms differentially impact these divergent B cell pathways. Rationale Blimp1 is found in Foxp3+ follicular regulatory T (TFR) cells known to impact GC B cell outcomes and play a role controlling antibody-mediated autoimmunity. In the context of infection, induced Blimp1 expression in CD4 T cells is expressed by conventional non-TFH effector cell compartments. Blimp1 segregates with emigrant CD4 T cells that leave the reactive lymphoid tissue to control innate immune function at the site of antigen entry. Conversely, Bcl6 is predominantly expressed in the GC regulating TFH pathway and is demonstrated to suppress Blimp1 expression. Germline ablation of Bcl6 exaggerates type 2 effector TH cell functions that promote excessive antibody production in the absence of the GC reaction. Similarly, loss of Bcl6 in CD4 T cells abrogates GC formation and post-GC PC responses, however multiple recent reports indicate continued support for antibody production without a Bcl6+ TFH compartment. To reconcile these findings, we propose a division of TFH function with separable pathways to regulate PC and GC differentiation. We hypothesize a central role for persistent CD4 T cell expressed Blimp1 that segregates early TFH transcriptional control to create an effector cell program that selectively targets PC differentiation. Results Direct intracellular staining for protein, confirmed with single Blimp1 and dual (Foxp3) reporter mice, identified Blimp1 expressing CXCR5+PD1hi TFH and TFR subsets within the spleen, bone marrow and other lymphoid tissues at steady-state. Conditional deletion of Prdm1 in CD4 T cells and adoptive transfer into immunodeficient hosts with splenic B cells, truncated both early pre-GC and late post-GC formation of PC providing a causal link to both pathways of differentiation in vivo. Across steady-state splenic T cells, in vitro activated Blimp1+CD25- CD4 T cells in T-B cell co-cultures correlated with significant levels of PC induction. Integrated single cell-indexed strategies segregate the transcriptional programs of Blimp1 expressing TFH cells (referred to here as PC-TFH) from canonical GC-inducing Bcl6+ TFH cells (GC-TFH), both distinct from Blimp1+ TFR cell programs in the steady-state. Immunization and recall produce follicular localized PC-TFH with pMHCII-tetramer binding memory response TFH cells that segregate across PC-TFH and GC-TFH compartments re-iterating the dichotomous transcriptome seen at steady-state. Conclusion This study identifies Blimp1 as a key mediator of PC-TFH cells that sub-specialize as inducers of PC differentiation and bifurcate from the Bcl6+ GC-TFH cell pathway and functions. Persistent PC-TFH compartments assort across multiple lymphoid tissues at steady-state and are distinct from Foxp3+Blimp1+ TFR immune regulators. While PC TFH cells alone are required for early and rapid antibody responses, both TFH sub-classes are essential to the generation of high-affinity long-lived and memory response PC compartments. Cellular organization and molecular components of the PC-TFH transcriptional program indicate functional sub-specialization that can be separately targeted for immunotherapeutic purposes and adjuvant design in future vaccines. Sub-specialized Blimp1+ PC-TFH cells control PC differentiation Adaptive immune protection requires balancing the evolution of BCR affinity within germinal center (GC) B cells and the differentiation of plasma cells (PC) for production of antibodies. Both functional B cell pathways require the antigen-specific induction of specialized CD4+ follicular T (TFH) cells. Within GC-inducing TFH cells, Bcl6 is required to drive the formation and function of GC B cells. Here, we segregate PC-inducing TFH cells that require Blimp1 as a key mediator of antigen-specific PC differentiation. The Blimp1+ PC-TFH transcriptional program diverges from Bcl6+ GC-TFH compartment and Blimp1+Foxp3+ follicular regulatory T (TFR) compartments. Antigen-specific PC-TFH emerge and segregate rapidly from GC-TFH after priming and recall to co-operatively induce effective long-term adaptive immunity.

Adaptive B cell immunity rapidly emerges to form plasma cells (PC) for antibody production and non-PC that enter germinal centers (GC) to evolve higher affinity B cell receptors. Both pathways are essential to long-term high-affinity immune protection. The early PC to GC cell fate division is driven by B cell expression of mutually antagonist transcriptional repressors Blimp1 and Bcl6.

This dichotomous B cell outcome is orchestrated through antigen-specific contact by follicular helper T (TFH) cells that express Bcl6 to upregulate CXCR5, localize into B cell regions and express transcriptional programs that influence B cell fate and function. It remains unclear what TFH cell mechanisms differentially impact these divergent B cell pathways.

Blimp1 is found in Foxp3 + follicular regulatory T (TFR) cells known to impact GC B cell outcomes and play a role controlling antibody-mediated autoimmunity. In the context of infection, induced Blimp1 expression in CD4 T cells is expressed by conventional non-TFH effector cell compartments. Blimp1 segregates with emigrant CD4 T cells that leave the reactive lymphoid tissue to control innate immune function at the site of antigen entry. Conversely, Bcl6 is predominantly expressed in the GC regulating TFH pathway and is demonstrated to suppress Blimp1 expression. Germline ablation of Bcl6 exaggerates type 2 effector TH cell functions that promote excessive antibody production in the absence of the GC reaction. Similarly, loss of Bcl6 in CD4 T cells abrogates GC formation and post-GC PC responses, however multiple recent reports indicate continued support for antibody production without a Bcl6 + TFH compartment. To reconcile these findings, we propose a division of TFH function with separable pathways to regulate PC and GC differentiation. We hypothesize a central role for persistent CD4 T cell expressed Blimp1 that segregates early TFH transcriptional control to create an effector cell program that selectively targets PC differentiation.

Direct intracellular staining for protein, confirmed with single Blimp1 and dual (Foxp3) reporter mice, identified Blimp1 expressing CXCR5 + PD1 hi TFH and TFR subsets within the spleen, bone marrow and other lymphoid tissues at steady-state. Conditional deletion of Prdm1 in CD4 T cells and adoptive transfer into immunodeficient hosts with splenic B cells, truncated both early pre-GC and late post-GC formation of PC providing a causal link to both pathways of differentiation in vivo. Across steady-state splenic T cells, in vitro activated Blimp1 + CD25 -CD4 T cells in T-B cell co-cultures correlated with significant levels of PC induction. Integrated single cell-indexed strategies segregate the transcriptional programs of Blimp1 expressing TFH cells (referred to here as PC-TFH) from canonical GC-inducing Bcl6 + TFH cells (GC-TFH), both distinct from Blimp1 + TFR cell programs in the steady-state. Immunization and recall produce follicular localized PC-TFH with pMHCII-tetramer binding memory response TFH cells that segregate across PC-TFH and GC-TFH compartments re-iterating the dichotomous transcriptome seen at steady-state.

This study identifies Blimp1 as a key mediator of PC-TFH cells that sub-specialize as inducers of PC differentiation and bifurcate from the Bcl6 + GC-TFH cell pathway and functions. Persistent PC-TFH compartments assort across multiple lymphoid tissues at steady-state and are distinct from Foxp3 + Blimp1 + TFR immune regulators. While PC TFH cells alone are required for early and rapid antibody responses, both TFH sub-classes are essential to the generation of high-affinity longlived and memory response PC compartments. Cellular organization and molecular components of the PC-TFH transcriptional program indicate functional sub-specialization that can be separately targeted for immunotherapeutic purposes and adjuvant design in future vaccines.

Adaptive immune protection requires balancing the evolution of BCR affinity within germinal center (GC) B cells and the differentiation of plasma cells (PC) for production of antibodies. Both functional B cell pathways require the antigen-specific induction of specialized CD4 + follicular T (TFH) cells. Within GC-inducing TFH cells, Bcl6 is required to drive the formation and function of GC B cells. Here, we segregate PC-inducing TFH cells that require Blimp1 as a key mediator of antigen-specific PC differentiation. The Blimp1 + PC-TFH transcriptional program diverges from Bcl6 + GC-TFH compartment and Blimp1 + Foxp3 + follicular regulatory T (TFR) compartments.

Antigen-specific PC-TFH emerge and segregate rapidly from GC-TFH after priming and recall to co-operatively induce effective long-term adaptive immunity.

Circulating antibodies that have been selected and redesigned to target previous exposure to foreign antigens are the major determinants of long-term adaptive immune protection (1-3).

This highly regulated outcome of adaptive B cell immunity is orchestrated by sub-specialized cohorts of follicular-localized CD4 T cells (4) (5) (6) . Differentiation into either antibody-secreting plasma cells (PC) or germinal center (GC) B cells requires antigen-specific contact with follicular helper T (TFH) cells (7, 8) . This dichotomous B cell fate decision requires B cell intrinsic expression of reciprocally antagonistic transcriptional repressors Blimp1 (encoded by Prdm1) and Bcl6 respectively. It remains unclear what TFH cell mechanisms differentially impact these dichotomous antigen-driven B cell pathways.

T cell intrinsic expression of Bcl6 is a central defining component of the GC-inducing capacity of TFH cells (9-11). In the absence of Bcl6, there is no GC formation, no BCR affinity maturation and no production of high-affinity memory B cells or post-GC PC (4, 12) . However, it was apparent, even from the earliest germline ablation studies, Bcl6 was not required for PC differentiation (13) (14) (15) . Across multiple germline KO models there was exaggerated type 2 helper T cell expansion and elevated PC formation in the complete absence of Bcl6. In T cell conditional deletion of Bcl6 with either adoptive transfer or within intact models, there was evidence for early residual (16, 17) and in some cases substantial (18, 19) continued support for TH dependent antibody production. Recent studies of human infection demonstrate neutralizing antibody production even with diminished TFH cells and GC formation (20) (21) (22) . There is also evidence for separable cellular (23) and molecular pathways (8, 24) of TH cells controlling the GC to PC fate decision. Nevertheless, Bcl6 expressing TFH cells are needed for GC formation and all downstream functions of the GC cycle, however we propose a separable transcriptional program drives PC differentiation.

Blimp1 is highly expressed in CD4 T cells and is associated with both effector and regulatory T cell functions. T cell conditional deletion of Prdm1 dysregulates immune homeostasis (25, 26) , decreases IL-10 production in Treg and TH1 cells and dampens the inflammatory program of TH17 cells. In the context of infection, Blimp1 promotes terminal differentiation in CD8 T cells (27) , assorts with decreased IL-2 production and the non-TFH CD4 T cell response that traffics to sites of antigen entry (28). Blimp1 is co-expressed with Bcl6 in Foxp3 + follicular regulatory T (TFR) cells (29, 30) that regulate TFH expansion, impact antibody-mediated autoimmunity, repress early PC formation and shape GC B cell clonal evolution (31, 32) . Recent studies demonstrate TFR compartments can repress PC formation within the GC and regulate post-GC autoantibody development (33). In addition, TFR can express the immunizing antigen specificity (34) and Foxp3 expressing GC-TFR cells can emerge from Foxp3 -GC-TFH to regulate GC shutdown at the terminal phase of the primary GC response (35). We propose a separate regulatory role for Blimp1 in TFR cells and hypothesize a central division of function within the TFH pathway where Blimp1 expression directs the induction of antigen-specific PC.

Here, we provide multiple layers of evidence for the bifurcation of a Blimp1 expressing PC-TFH pathway of differentiation with shared and divergent elements of a transcriptional program that segregates from Bcl6 + GC-TFH cells. In steady-state spleens, we observe Blimp1 + Foxp3 expressing TFR cells as a putative PC-TFR compartment with a related GITR + Foxp3 -PC-TFH subset expressing intermediate regulatory transcriptional signatures. Primary and recall immunization induces follicular-localized Blimp1 + Bcl6 -PC-TFH compartments with antigen-specific PC-TFH cells that rapidly emerge and transcriptionally segregate from Blimp1 -Bcl6 + GC-TFH cells. Therefore, persistent Blimp1 expression within Cxcr5 + PD1 hi TFH compartments programs the development of a separate sub-class of follicular CD4 T cells specialized to induce antigen-specific PC differentiation.

Steady-state murine spleens contain small but demonstrable levels of class-switched IgG B cells assorted across GC, memory B and PC compartments that emerge under the control of multiple follicular CD4 T cell compartments. Direct intracellular staining for Foxp3 protein and the activation marker CD44 permits separation of Foxp3 + CD4 T cell regulators from Foxp3 -CD44 hi TCRb expressing non-naive effector/memory T cell compartments ( Fig. 1A ; referred to here as effector TH; ETH). CXCR5, as the cardinal indicator of both splenic TFH and TFR cells, labels similar but lower levels of these follicular T cell subsets than CXCR5 -ETH and regulatory T (Treg) compartments at steady state. Direct intracellular labeling for Blimp1 protein, reveals significant steady-state Blimp1 + fractions within all splenic CD4 T cell compartments (Fig. 1A) . Although Blimp1 + ETH comprise the largest splenic compartment, only a small fraction of all steady-state splenic ETH expresses this transcriptional repressor. Similarly, Foxp3 + regulatory CD4 T cells coexpress Blimp1 with distribution between CD25 hi and CD25 lo Treg and TFR compartments (Fig.   S1A) . Notably, Blimp1 was expressed on separable fractions of CD25 lo CXCR5 + splenic TFH compartments not expected to co-express Bcl6.

Using a well-established protein immunization model (36, 37), we reveal substantial fractions of antigen-reactive Blimp1 expressing ETH as early as day 5 after initial priming (Fig.   1B) . These ETH compartments rapidly exit the draining LNs and without CD62L are unable to reenter. At this early stage of the immune response, substantial fractions of both Blimp1and Blimp1 + TFH cells accompany rapid and early antigen-specific PC differentiation prior to GC formation (Fig.1B) . Both TFH compartments continue to expand by day 7 of the primary response but remain at similar 2:1 ratios (Fig. S1B) . Hence, while Blimp1 expressing ETH comprise substantial fractions of the response to protein antigen, there were also emergent antigen-reactive Blimp1 expressing CXCR5 + TFH compartments.

To confirm and extend analysis of the steady-state Blimp1 + TFH compartment, we use a Blimp1-YFP reporter strain. In this strain, we use surface expression of TNFR-related protein GITR, that correlates positively with Foxp3 expression, to separate GITR -TFH from GITR + TFR splenic compartments. Using reporter expression, we find similar numbers and fractions of Blimp1and Blimp1 + compartments of ETH and TFH as observed using direct intracellular staining for protein (Fig. 1C ). Using this model, we demonstrate that PD1 expression is differentially expressed on both TFH subsets (Fig. 1D) indicating that these CXCR5 + compartments are most likely within GC microenvironments (38). All non-naive T cell compartments express higher levels of ICOS while the Blimp1 + ETH compartment contained a large subset with distinctively high levels of CD43. Thus, persistent Blimp1 expression in the steady-state spleen separates a subset of the ETH compartment and further segregates a Blimp1 + CXCR5 + PD1 hi TFH cell compartment.

Using the Blimp1-YFP reporter and GITR expression, we sorted Blimp1 + and Blimp1cells from both ETH and TFH subsets. We recently developed a single cell-indexed strategy to assess gene expression within these very rare subsets of CD4 T cells at steady-state (39). In this strategy, we couple fluorescence-based flow cytometry to quantitative and targeted RNA sequencing (single cell qtSEQ) to directly integrate cell surface phenotype with expression of target genes.

The targeted library formation uses semi-nested-PCR for high sensitivity amplification and library formation with digital deconvolution to track the cellular origin of the mRNA and for amplification adjusted quantification. Library size using this method is comparable to that seen with more global techniques, however, as these studies target ~500 genes, the dropout rate for individual cells is lower and sensitivity is ~10-fold higher for each assay at the single cell level. While throughput is low, single cell qtSEQ provides greater depth for the targeted assessment of transcriptional programs in rare, phenotypically-complex cellular compartments.

In this initial analysis, differential transcriptional programs segregate Blimp1and Blimp1 + ETH from each other and from Blimp1 + TFH compartments at steady-state (Fig. 1E) (Fig. 1G) , further highlighting the divergent nature of CD4 non-follicular effector/memory subsets in the steady-state spleen.

Blimp1 + TFH compartments also segregated from naïve T and both ETH subsets (Fig. 1F) .

Contributing to these differences are notable transcriptional regulators (eg Prdm1, Klf4, Ascl2, Stat4, Nfatc1 and Irf1, surface modulators of location (eg Cxcr5, Cxcr3, S1pr4) and intercellular contact (eg Pdcd1, Havcr2, Spn, Cd81, Icam2, Entpd1) with differential expression of cytosolic machinery (eg Rc3h1, S100a6, Blk) and secreted molecules (eg Ccl3, Ccl5) prominent in the Blimp1 + TFH compartment. These trends introduce broad patterns of divergence at a level of the transcriptional program that potentially regulate separable cellular functions.

Next, we developed a dual reporter model introducing both Blimp-YFP and Foxp3-Thy1.1 together to separate TFH and TFR cells and their respective Blimp1 expressing sub-compartments.

As expected, there are lower numbers of conventional Treg cells in female spleens, however, the ratio of Blimp1to Blimp1 + appears similar to males (Fig. 1I & S1B) . In this dual reporter model, there were similar numbers and dominance of Blimp1 -CXCR5 -PD1 -ETH over the Blimp1 + subcompartment as seen in the single Blimp1 reporter using GITR expression to exclude Treg. The follicular compartments were larger overall in female spleens with similar numbers of Blimp1 -TFR but lower fractions and number of Blimp1 + TFR cells. There were similar compartments of Blimp1 -TFH but consistently higher numbers and fractions of Blimp1 + TFH cells in female spleens (Fig. 1I) .

Small but discernible fractions of Blimp1 + CXCR5 + PD1 hi TFH and TFR compartments can be found consistently in the bone marrow, mesenteric LNs and Peyer's Patch lymphoid tissues (Fig. S1B) .

While the balance altered considerably, there was consistent presence of both Blimp1 expressing TFH and TFR compartments across central and peripheral lymphoid tissues at homeostasis.

Prdm1 is a major transcriptional repressor central to the formation and function of antigenspecific PC differentiation in B cells (40). As described previously, germline conditional ablation of Prdm1 in T cells introduces complex interdependent phenotypes with multiple levels of impact at T cell development, peripheral regulatory and effector TH cell functions (25, 26). Here, we chose an adoptive transfer model in which naive TH cells transferred into immunodeficient RAG1 def recipients become activated, expand and differentiate into a spectrum of B cell helper compartments. Resultant CD4 T cells drive class-switched PC differentiation within 14 days and delayed GC formation occurs by day 28 after transfer with or without intentional immunization (23) . Here, we sorted and separated CD4 T cells and CD19 + B cells from Prdm1 fl/fl -Rosa26 CreERT2 spleens. This mature CD4 T cell compartment was treated with tamoxifen or vehicle in vitro for 1h driving >90% deletion of target gene, before adoptive co-transfer with untreated splenic B cells.

In the first series of studies, we targeted a late timepoint to permit GC formation and sufficient time to decrease short-lived PC known to have 3-5 day half-life in vivo . At day 28, the reactive CD4 T cell compartment was >90% activated CD44 hi CD62L lo T cells with similar numbers regardless of treatment ( Fig. 2A) . Distribution of CD25 and CXCR5 was also broadly similar suggesting the capacity for a broad range of functional outcomes (Fig. 2B) . The transferred T cell compartments supported equivalent amounts of GC formation (Fig. 2C) , no change in memory B cell numbers ( Fig. S2C ) but significantly truncated class-switched PC differentiation (Fig. 2D) .

Next, we targeted the delayed pre-GC PC differentiation pathway at day 14 after treatment and transfer. Transferred splenic B cells, expand with predominantly IgD -IgM + B cells and IgD -IgMclass-switched B cells present (Fig. S2D ) before any GL7 hi CD38 lo GC formation (Fig. S2E) . We detected substantial baseline PC formation that is likely T cell independent after transfer into these immunodeficient recipients. Nevertheless, there was significant truncation of both IgM and classswitched PC formation after CD4 conditional and tamoxifen-induced temporal deletion of Prdm1 ( Fig. 2E,F) . This flow cytometry-based analysis was confirmed using IgG specific EliSPOT assessment for frequencies of antibody-secreting cells (Fig. 2G) . Taken together, these studies provide a causal link between CD4 T cell expression of Prdm1 and both pre-GC and post-GC pathways of PC differentiation in vivo.

To narrow down which steady-state mature splenic CD4 T cell compartment was responsible for PC differentiation, we established in vitro activated TH-B cell co-cultures (Fig. 3A) .

Sorted T cells are polyclonally activated in vitro for 2 days and then 'rested' without TCR triggers in IL2 alone for 2 days before addition of Blimp1 -CD19 + B cells for a further 5 days prior to assay for PC differentiation. Using the Blimp1-YFP reporter spleens, we isolated GITR -Blimp1 -CD4 T cells (ETH and conventional TFH), Blimp1 + GITR -CD4 T cells (ETH and TFH) and Blimp1 + GITR + CD4 T cells (Blimp1 + Treg and TFR) (Fig. 3B) . Naive T cells were used in all co-cultures and help to establish baseline PC differentiation without addition of non-naive T cell subsets. At day 9, in vitro co-cultured T cells were assessed for Blimp1-YFP expression by flow cytometry (Fig. 3C) .

Some wells defined as Blimp1 -T cells at the time of sorting upregulated Blimp1 in vitro (~64%), However, no naive T cells upregulated Blimp1 in these cultures and most Blimp1 expression correlated with pre-existing levels on sorted populations.

The CD4 T cells with newly-expressed Blimp1 assorted as either CD25 + or CD25 lo with the latter representing highest penetrance across all conditions (Fig. 3D,E) . Using both CD138 and Blimp1 expression on IgM and class-switched B cells as a measure of PC differentiation, we found significant amounts of IgM, non-IgM class-switched and IgG1 PC only in co-cultures containing in vitro activated CD25 -Blimp1 + CD4 T cells (Fig. 3F,G) . In these studies, IgM and IgG1 secretion was confirmed using specific EliSPOT assays (Fig. 3H) . Thus, in vitro T cell functional assays correlate Blimp1 expression in CD25 lo TH cells to the promotion of both IgM + and classswitched PC differentiation.

Using the dual reporter model, we separated Foxp3and CXCR5 + PD1 hi TFH compartments from steady-state spleens based on Blimp1-YFP expression for single cell qtSEQ analysis (Fig.   4A ). These high-fidelity single cell sorts selected CD4 + TCRb + T cells expressing high levels of CD44 and PD1 that were mostly ICOS high, with varying levels of CD62L that largely correlated with Ly6C (Fig. S3A) . Foxp3 -Blimp1 -TFH cells were all GITR -CD25and will be referred to here as the GC-TFH compartment. In contrast, Foxp3 -Blimp1 + TFH cells were further divided by GITR and CD25 expression with the GITR -CD25 lo compartment most closely aligning with PC-inducing function and will be referred to here as the PC-TFH compartment. TSCAN analysis using gene expression only and PCA broadly segregates the single cell transcriptional programs of GC-TFH and PC-TFH from naive T cells and each other (Fig. S3B) , while volcano plots highlight significant differences between the two major TFH subsets (Fig. S3C) . However, separate comparisons of each TFH subset to naive T cells reveals multiple shared and many uniquely upregulated elements that define and differentiate the GC-TFH and PC-TFH transcriptome at homeostasis (Fig. 4B, S3C- 

To display the similarities and differences between GC-TFH and PC-TFH we used circle plots that represent not only average gene expression but also percent positive for targeted assays (Fig 4C, S3G) . Results have been ordered hierarchically to emphasize gene targets with highest expression and greatest penetrance and separated broadly by where the protein product is expressed within the cell (membrane, cytosol/secreted and nuclear). As expected, multiple mRNA species expressed in naive T cells significantly decrease upon TFH differentiation into either pathway (eg Ccr7, Sell, Txk, Bcl2, Foxj1, Lef1). Many target genes were significantly more To emphasize the shared attributes of these follicular T cell compartments, network analysis using Metascape (41) revealed multiple enriched onotology clusters involving T cell activation, positive and negative immune response mediation, and cytokine and chemokine production that are similarly significant in both pathways (Fig. 4D) . Interrogation of predicted protein-protein interactions (Fig. 4E ) revealed common pathways used by both subsets involving T cell activation pathways, co-stimulation, CD4 T cell differentiation and chemokine and cytokine regulation. However, while many of the molecular components in these pathways were shared between subsets, multiple others were uniquely expressed. These trends indicate mechanistic differences in how each compartment is reacting to, or has previously reacted to, immune challenge. Taken together, these results indicate multiple shared and divergent elements of follicular T cell transcriptional programing that reveal the bifurcation of GC-TFH and PC-TFH pathways of differentiation.

As discussed, Blimp1 expression is most typically associated with Foxp3 expressing TFR cells that exert a negative regulatory function on B cell differentiation (29, 30). Using the dual reporter model, we could readily segregate a minor Blimp1 + TFR subset from the majority Blimp1 -TFR compartment (Fig. 4A, S4A) . However, there was also a substantial compartment of Foxp3 -Blimp1 + TFH cells that expressed GITR, a protein also associated with regulatory function (Fig.   S4A ) . Based on differential protein expression, including higher Blimp1, PD1, CD25, ICOS and lower Ly6C, these GITR + Blimp1 + TFH cells most closely track with the Blimp1 + TFR compartment and predict regulatory function (Fig. S4B) . In support of this division, the GITR -PC-TFH express higher levels of TFH associated transcriptional regulators Bcl6 and Tcf7 while the GITR + Blimp1 + TFH subset express multiple immune checkpoint molecules such as Ctla4, Tnfrsf18, Havcr2 and Tigit (Fig. S4C ). More broadly, the transcriptional program of these cells, referred to here as GITR + PC-TFH cells, express more distinct elements from GC-TFH and PC-TFH compartments and greater overlap with the Blimp1 + TFR compartment (eg Tnfsf18, Ctla4, Havcr2, Ikzf4, Klrg1 and Prdm1) (Fig. 5A, S4D) .

Clustering naive TH cells with these four non-naive CD4 compartments further supported the alignment of GC-TFH and PC-TFH transcriptional programs (Cluster 1 higher shared levels Dock8, Stat3, Tcf7, Bcl6, Slamf6, Cxcr5, Cd28) and the GITR + PC-TFH with Blimp1 + TFR compartment (Cluster 0, higher shared levels Il10, Ctla4, Tnfrsf4, Klrg1, Tnfrsf8, Tnfrsf18) Fig.

A separate cluster (Cluster 2; Cxcr3, Tbx21, Ifng) comprises more shared type 1 activities across all compartments than attributes that divide TFH and TFR. Hence, we conclude that the GITR + PC-TFH compartment expresses more regulatory than helper attributes and may represent a transitional state between the GITR -PC-TFH and its Blimp1 + TFR counterpart.

For further assessment of the Blimp1 associated follicular regulatory program, we compared each subset to naive TH cells to highlight the significantly different but shared or unique features of this regulatory program ( Fig. 5E; S4E ,F). Many well-described examples of this shared regulatory program (eg Tnfrs4, Tigit, Pdcd1, Ctla4) are highly expressed mRNA species associated with inter-cellular contact, control and secreted or cytosol expressed molecules ( Fig.   5F ). Shared transcriptional regulators also abound with known action in lymphocyte differentiation. In contrast, there are many examples of uniquely membrane, secreted/cytosol and nuclear expressed molecules that may define the transitional progress from the GITR + PC-TFH compartment towards the Blimp1 + TFR program (Fig. 5G) . Thus, both compartments express broadly regulatory transcriptional programs that may target PC differentiation in ways that broadly correspond to facets of GC-TFR control of GC B cell function.

We have provided multiple layers of evidence for separable PC-TFH and GC-TFH follicular T cell compartments after initial antigen priming and in the steady-state immune system. The steady-state spleen is further complicated by the existence of adaptive immune tolerance mechanisms that manage commensal and environmental antigens (42, 43). However, steadystate spleens would also contain effector B and T cell compartments reactive to foreign antigens with many expected to be in a persistently altered but quiescent memory state.

Next, we focus on sampling the transcriptional programs of antigen reactive memory TFH compartments. We chose a simple protein antigen model, priming with chicken ovalbumin and a TLR4 agonist adjuvant (Monophosphoryl lipid A; MPL) with repeat immunization >10 weeks for recall. Using Ova-I-A b tetramer labeling, we sorted single antigen-activated CD44 hi pMHCII + CXCR5 + memory response TFH cells 4 days after challenge for gene expression analysis (Fig.   6A ). Immunofluorescence for Bcl6 and Blimp1 protein revealed CD4 + T cells expressing either transcription factor in the follicular B220 + B cell regions of reactive lymph nodes (Fig. 6B) .

Quantifying the distribution of these follicular subsets displays lower fractions of Blimp1 + Bcl6 -PC-TFH cells than Blimp1 -Bcl6 + GC-TFH following soluble versus adjuvant inclusion at recall. The significant increase in PC-TFH cells with adjuvant correlates with earlier studies indicating the increased impact of MPL on memory PC expansion (44). Nevertheless, this imaging analysis ascertains the follicular localization of a Blimp1 + Bcl6memory response PC-TFH compartment.

For gene expression studies, we chose the Biomark platform that targets 96 genes for amplification and uses qPCR for quantification. As with previous qtSEQ analysis, we used cell indexing to directly sort rare populations of antigen-specific TFH compartments and included a nested PCR intron targeting for each assay in library formation to increase the sensitivity for each assay. The high sensitivity and penetrance frequencies are displayed as calculated arbitrary units of mRNA for a representative set of target genes with estimates for the proportion of positives expressing each signal (Fig. 6C) . Unsupervised K means clusters predicting three divisions by two subsets broadly segregates a set of high penetrance shared gene expression with separation of mRNA species associated with Bcl6 expressing GC-TFH and a set associated with Prdm1 expressing PC-TFH (Fig. 6D) .

Due to recent antigen-specific activation there is high expression and frequency for most of the shared genes across both sub-populations as shown in the example. A series of commonly expressed cytokine receptors and surface molecules (eg Il2rg, Tgfbr2, Il10rb, Ifnar2, Ifnar1, Il6st, Spn) accompany multiple transcription factors known to influence lymphocyte differentiation (eg Across multiple experiments, we accumulated many examples of pMHCII + TFH cells that expressed the major regulators Bcl6, Prdm1 and Foxp3 (Fig. 6E) . The vast majority of Bcl6 expressing GC-TFH cells at this timepoint did not co-express Prdm1 or Foxp3. Similarly, the majority of Prdm1 expressing PC-TFH did not express Bcl6 or Foxp3. However, half of the Foxp3 expressing TFR cells co-expressed Prdm1 in a manner resembling the Blimp1 + TFR regulatory compartment seen at steady-state. Unlike typical TFR compartments known to be self-reactive, these Blimp1 + TFR cells are sorted based on shared antigen-specificity. This latter compartment could be considered putative PC-TFR cells that negatively impact memory-response reactivation to select higher affinity memory B cells into PC differentiation at recall.

Focusing analysis on the GC-TFH to PC-TFH transcriptional division, we compared the gene expression across these compartments directly. The volcano plot displays a set of significant differences with antigen-specific GC-TFH expressing higher levels of multiple genes associated with the GC pathway (eg Cxcr5, Pdcd1, Tox, Id3, Btla, Tnfsf8) contrasting with antigen-specific Prdm1 + PC-TFH differential surface expression of Spn (CD43), Ctl4a and transcriptional regulators Klf7, Irf4, and Runx3 (Fig. 6F ). Using these key differences, dimensionality reduction separates these compartments into separate regions to segregate these single antigen-reactive cells across the GC-TFH and PC-TFH compartments (Fig. 6G) . These results demonstrate the rapid emergence of divergent follicular pathways with evidence for antigen-specific Blimp1 expressing TFR cells and separate pathways of Bcl6 + GC-TFH and Blimp1 + PC-TFH at antigen recall. 38) impacting B cell outcomes through dynamic and varied inter-cellular cognate contact (6, 38, (45) (46) (47) . The molecular rules of cellular exit from the GC reaction are less well understood (2, 48, 49) . Quantitative differences in TFH-GC B cell contact duration and quality play a role (6, 50) . B cell transcriptional changes occur to down-regulate Bcl6 and permit alternate programs and outcomes. One dominant outcome is the upregulation of Blimp1 and the elaborate reprogramming of post-GC PC differentiation (40, 51). Here, we propose that cognate contact with PC-TFH, either within the GC or upon GC exit, is required to imprint this terminal differentiation program and evoke continued secretion of high-affinity antibody.

Multi-targeted transcriptional repression exerts its function in cell-type and differentiationstage specific ways (4, 12) . As described, CD4-expressed Prdm1 is highly heterogenous in its impact on effector and regulatory T cell functions with influence during early T cell development Here, we demonstrate that Blimp1 expression also segregates the CXCR5 + PD1 hi TFR compartment and speculate that the distribution of this known TFR associated molecule differentially associates with PC-regulating functions. Surprisingly, we also detected large fractions of GITR + Blimp1 + TFH that did not express Foxp3 in the steady-state. Gene expression analysis of these two compartments indicates the presence of multiple immune checkpoint inhibitors with less effector enhancing capacity, consistent with a negative regulatory function for both subsets (31). Furthermore, antigen specificity of TFR action remains controversial (34) with recent evidence for the conversion of GC-TFH to GC-TFR (35). Here, foreign antigenspecificity is shared across memory TFR subsets of both Foxp3 + Bcl6 + GC-TFR and Foxp3 + Bcl6 -Blimp1 + TFR that may be limiting PC differentiation as an early outcome of the GC reaction. Based on the distribution of Blimp1 and Bcl6, we propose the existence of separable Foxp3 + GC-TFR and PC-TFR follicular regulatory compartments.

These follicular helper sub-compartments are central to multiple aspects of adaptive immunity with relevance to recent reports of adaptive immune tolerance, the tumor microenvironment, infectious disease and vaccine responses. We recently reported the impact of PD1 blockade on adaptive immune tolerance that selectively dysregulates a type 2 GC-TFH program (42) and exaggerates IgG1 GC B cell expansion and excessive amounts commensal reactive antibodies that may involve separate levels of regulation (43). Recent reports indicate that TFH cells and B cells in the tumor microenvironment are also key to immune checkpoint therapy indicating another broad application of our current findings in this clinical setting (55). The range and dynamics of the immune response in humans with COVID-19 has been probed at great depth with a spectrum of CD4 TH attributes driving B cell helper functions that correlate with protection (56-59). Some trends indicate regulatory CD4 involvement (60) and correlations of circulating TFH cells with convalescence or expression of mild disease in this infection (61, 62) . In acute COVID-19, extrafollicular B cell responses alone were insufficient for protection (20) and the TFH compartment can be compromised upon infection leading to decreased GC B cell formation and lower quality antibody responses (21) . SARS-CoV2 mRNA vaccines induce increased presence of local TFH and GC B cell responses that correlate with immunity (63) . Similar correlations are found in malaria infection (64) , influenza vaccination (65) and long-lived TFH compartments that support humoral immunity (66) . Thus, a division of function in these central and potentially inter-dependent foreign antigen-driven TFH functions must be considered across multiple facets of follicular T cell controlled B cell adaptive tolerance, tumor development and immunity to infection.

While PC-TFH cells alone are required for early and rapid antibody responses, both TFH sub-classes are essential for generation of high-affinity long-lived PC compartments. Recent studies demonstrate non-TFH cells lacking Bcl6 that drive class-switch and PC differentiation (19) .

It is plausible that Blimp1 expressing ETH localizing close to the T-B borders can direct PC fate or alternatively these Bcl6 -TH cells more closely resemble Blimp1 + PC-TFH described here.

Specialized GC-TFH subsets are also reported with functions that selectively regulate isotypespecific B cell responses (37, 42, 67, 68). It is of interest to speculate whether these divided traits extend into the PC-TFH compartment. Selectively targeting memory PC-TFH compartments also provides the means to bias memory B cell fate at antigen recall to enhance long-term immunity.

Cellular organization and molecular components of PC-TFH transcriptional program indicate functional sub-specialization with pathways that can be separately targeted for immunotherapeutic purposes and adjuvant design in future vaccines.

BioRender.com was used to construct the graphical summary. Competing interests: There are no competing interests. Scatter plot of single cell RNA-seq (qtSEQ) differential gene expression in naïve to GITR + Blimp1 + TFH (x-axis) and naïve to Blimp1 + TFR (y-axis). Colored dots indicate p-value <0.05. Plots display commonly upregulated genes with no significant difference between GITR + Blimp1 + TFH and Blimp1 + TFR expression (left; blue), commonly upregulated genes, but significantly different GITR + Blimp1 + TFH and Blimp1 + TFR expression (center; orange, Blimp1 + TFR; blue, GITR + Blimp1 + TFH), and uniquely upregulated genes in either GITR + Blimp1 + TFH or Blimp1 + TFR (right; orange, Blimp1 + TFR; blue, GITR + Blimp1 + TFH). F) A dot plot display of differentially expressed genes across naïve, GITR + Blimp1 + TFH and Blimp1 + TFR depicting shared genes or G) unique genes, as described in (E). Dot color reflects average gene expression and dot size depicts population penetrance. Single cell RNAseq analysis from two independent experiments with 3-4 mice per experiment. 

Sell S1pr1 S1pr4 Notch2 Cd40lg

Ctla4 Cd2  Tnfrsf4  Tnfrsf1b  Havcr2  Cd244  Selp  Cd86  Cd81  Ifngr1  Icos  Cd44  Tnfrsf9  Icam1  Cd83  Tigit  Il22ra2  Tnfsf18  Il12rb1  Pdcd1  Ifnar2  Itgb1  Lilrb4  Tnfrsf13c   Foxj1  Lef1  Ccnd2  Ets1  Tcf7  Polh  Relb  Cdkn1b Gata3 

Foxo1 Tgfb1  Il2rg  Smad4  Mta3  Irf2  Tcf12  Tgfbr2  Spn  Runx1  Ikzf2  Klf6  Il10rb  Ifnar2  Ifngr1  Ifnar1  Il6st  Runx3  Slamf1  Il2rb  Bcl6  Gata3  Cd5  Pdcd1  Tnfsf8  Cd40lg  Tox  Maf  Icos  Sh2d1a  Helios  Ltb  Il27ra  Id3  Cxcr3  Btla  Nrp1  Prdm1  Tlr4  Klf7  Tcf3  Tlr9  Il10ra  Icam1  Il21r Ccr7 Il7r 

Single cell suspensions of spleen, lymph node, or femur bone marrow were prepared and processed as previously described (44). For intracellular staining, cells were additionally incubated with eFluor780 viability dye (ThermoFisher) for 15 minutes and then processed using the Foxp3 staining kit (ThermoFisher) per manufacturer's protocol. Cells were then stained for transcription factors Blimp1 (BD Biosciences) or Foxp3 (eBioscience) for 30 minutes. All flow cytometry was performed on a four-laser FACS Aria III using Diva 8.0 software (BD). Downstream analyses, including index sort plate-mapping and tSNE visualization, were performed using FlowJo software (Version 10, TreeStar).

Single-cell suspensions of 2.5x10 6 CD4 + T cells and 1x10 7 CD19 + B cells were sorted separately via flow cytometry from Prdm1 f/f Cre-ER T2 spleens. CD4 + T cells were then transferred to complete RPMI media (10% fetal bovine serum) and treated with 1μM 4-hydroxytamoxifen (Sigma) freshly diluted in 95% ethanol for 1 hour at 37°C. CD4 + T cells were washed 3 times in complete RPMI media, combined with the untreated CD19 + B cells and transferred through intraperitoneal injection into Rag1 defrecipient mice.

Splenic CD4 + T cells were isolated from Blimp1-YFP reporter mice and separated using flow cytometry based on phenotype. Twenty thousand activated T cells were combined with sixty thousand naïve T feeder cells in 96 well plates with 1μg/mL α-CD3ε (Bio X Cell), 2.5μg/mL CD28 (Bio X Cell) and 10U/mL IL-2 (Sigma) in complete RPMI. After 48 hours, T cells were replated into new wells. At 96 hours, 3x10 5 CD19 + B cells were added to pre-existing wells containing T cells and supplemented with 200ng/mL BAFF (Sigma) in complete RPMI for 5 days. Plasma cells were analyzed by flow cytometry and Elispot.

Multiscreen HTS plates were coated with IgM, total IgG or IgG1 (BioLegend) at 4°C overnight.

Cells were added to each well and incubated at 37°C. After 18 hours, wells were incubated with the secondary antibody conjugated to horse radish peroxidase (Southern Biotech) and developed using a filtered solution of 0.2mg/mL 3-amino-9-ethylcarbazole (Sigma) and 0.015% H2O2 (Sigma) in 0.1M sodium acetate (pH 4.8-5.0, Sigma) for 3-8 minutes. Wells were washed with H2O and allowed to dry at least 48 hours before visual inspection of spots and manual enumeration using a stereomicroscope.

Lymph nodes were collected and stained for flow cytometry. For tetramer staining, cells were 

Draining LNs were fixed overnight at 4 °C in paraformaldehyde-lysine-periodate buffer, dehydrated in 30% sucrose, embedded in OCT medium (Tissue-Tek) and frozen on dry ice. Tissues sections were sliced into 8μm sections and processed as previously described (44). Tissues were stained with α-B220 (BioLegend), α-CD4 (GK1.5), α-Blimp1 (Santa Cruz) and α-Bcl6 (BD Biosciences). Slides were examined using the Nikon C2 confocal microscope with four lasers (408 nm, 488 nm, 543 nm and 633 nm) and a 60× objective. Images were acquired with Nikon Elements software and were further processed with Adobe Photoshop.

T cells were sorted from single Blimp1-YFP reporter or dual Blimp-YFP/Foxp3-Thy1.1 spleens into 384-well plates, with index sort information collected on each cell: naive (CD8 -B220 -

Blimp1 + ETH (CD8 -B220 -CD4 + TCRb + CXCR5 -GITR -Blimp1 + ) for single Blimp1YFP reporter sorts.

Doublets were excluded using SSC-A and SSC-H parameters.

Transcriptional analysis of single cells was carried out using a custom RNA sequencing protocol, quantitative and targeted single cell sequencing (qtSEQ) (39). As previously described, this technique sequences polyA mRNA using a nested set of 3' targeted primers to amplify specific gene (37, 42, 43, 71 

Steady state splenocytes were sorted for single cell RNAseq analysis from activated CXCR5+ subsets. A) Index sort of follicular T (B220-CD8-TCRβ+CD4+CD44+Cxcr5+) subsets displaying PD-1 and GITR expression within GC TFH (Blimp1-GITR-Thy1.1-), PC TFH (Blimp1+GITR+/-Thy1.1-) and Blimp1+ TFR (Blimp1+GITR+Thy1.1+) and B) differential protein expression within sorted subsets displayed as histograms. C) Differential gene expression from single-cell RNAseq (qtSEQ) analysis on PC TFH comparing GITR+ and GITR-subsets displayed in (A) as a volcano plot (left) and dot plot (right). Dot color reflects average gene expression and dot size depicts population frequency. D) Volcano display of differential gene expression within sorted TFH subsets GC TFH and GITR+ PC TFH (left), GC TFH and Blimp1+ TFR (center) and Blimp1+ TFR and GITR+ PC TFH (right) sorted in (A). E) A volcano display of differential gene expression in Blimp1+ TFR to naive and GITR+ PC TFH to naïve depicting shared genes upregulated in both data sets and F) genes uniquely upregulated in GITR+ PC TFH (top) or Blimp1+ TFR (bottom). Numbers in flow plots display mean±SEM (n=8). Single cell RNAseq analysis (qtSEQ); B-E) included post-QC subsets of GC TFH (n=304), PC TFH (n=248) and naïve T (n=153) from two independent experiments with 3-4 mice per experiment.

Molecular programming of B cell memory

Revealing T follicular helper cells with BCL6

Follicular helper T cells

T follicular helper cells in space-time

Germinal center B cell and T follicular helper cell development initiates in the interfollicular zone

SAPcontrolled T-B cell interactions underlie germinal centre formation

Bcl6 mediates the development of T follicular helper cells

Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation

Bcl-6 is the nexus transcription factor of T follicular helper cells via repressor-of-repressor circuits

The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation

Disruption of the Bcl6 gene results in an impaired germinal center formation

Control of inflammation, cytokine expression, and germinal center formation by BCL-6

Insights into the role of Bcl6 in follicular Th cells using a new conditional mutant mouse model

B cell priming for extrafollicular antibody responses requires Bcl-6 expression by T cells

Cutting Edge: T Cell-Dependent Plasmablasts Form in the Absence of Single Differentiated CD4(+) T Cell Subsets

High-affinity, neutralizing antibodies to SARS-CoV-2 can be made in the absence of T follicular helper cells. bioRxiv

Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19

Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19

Protective neutralizing influenza antibody response in the absence of T follicular helper cells

Developmentally distinct Th cells control plasma cell production in vivo

Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4(+) T Cells in COVID-19

Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19

Spike-specific circulating T follicular helper cell and crossneutralizing antibody responses in COVID-19-convalescent individuals

Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individuals. medRxiv

Transcriptome dynamics of CD4(+) T cells during malaria maps gradual transit from effector to memory

Impaired HA-specific T follicular helper cell and antibody responses to influenza vaccination are linked to inflammation in humans

Opposing effects of T cell receptor signal strength on CD4 T cells responding to acute versus chronic viral infection